Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study

Puneet Misra, Shashi Kant, Randeep Guleria, Sanjay K Rai, WHO Unity Seroprevalence study team of AIIMS
doi: https://doi.org/10.1101/2021.06.15.21258880

Data Availability

yes available with us and WHO

Back to top
Posted June 16, 2021.
Download PDF
Data/Code
Email
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study
Puneet Misra, Shashi Kant, Randeep Guleria, Sanjay K Rai, WHO Unity Seroprevalence study team of AIIMS
medRxiv 2021.06.15.21258880; doi: https://doi.org/10.1101/2021.06.15.21258880
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area